These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14378882)

  • 1. [Relatively quick passage to a positive lepromin reaction in four patients with lepromatous leprosy].
    MERKLEN FP; RIOU M
    Bull Soc Fr Dermatol Syphiligr; 1955; 62(1):45-8. PubMed ID: 14378882
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary trial of intervention levamisole therapy in persistently bacteriologically positive lepromatous leprosy.
    Ramu G; Sengupta U
    Lepr India; 1983 Jan; 55(1):64-7. PubMed ID: 6876762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report.
    Kar BR; Job CK
    Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The late lepromin reaction in subsided lepromatous cases.
    MUKERJEE N; KUNDU S
    Int J Lepr; 1961; 29():14-9. PubMed ID: 13773641
    [No Abstract]   [Full Text] [Related]  

  • 5. Similar alteractions of lymphoblastic dedifferentiation in lepromatous leprosy patients and their healthy lepromin-negative consanguineous offspring.
    Balina LM; Fliess EL; Bachmann A; Cardama JE; Gatti JC
    Int J Lepr Other Mycobact Dis; 1973; 41(1):7-13. PubMed ID: 4795537
    [No Abstract]   [Full Text] [Related]  

  • 6. A recessive major gene controls the mitsuda reaction in a region endemic for leprosy.
    Ranque B; Alcais A; Thuc NV; Woynard S; Thai VH; Huong NT; Ba NN; Khoa PX; Schurr E; Abel L
    J Infect Dis; 2005 Oct; 192(8):1475-82. PubMed ID: 16170767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological analysis of the Mitsuda reaction in contacts of multibacillary leprosy patients.
    Trindade MA; Fleury RN
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):109-10. PubMed ID: 8326174
    [No Abstract]   [Full Text] [Related]  

  • 8. [Can a positive lepromin reaction caused by repeated injections of lepromin perhaps be considered as a sign of antileprous immunity].
    MONTESTRUC E
    Bull Soc Pathol Exot Filiales; 1959; 52(1):11-2. PubMed ID: 13671305
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibility to leprosy may be conditioned by an interaction between the NRAMP1 promoter polymorphisms and the lepromin response.
    Ferreira FR; Goulart LR; Silva HD; Goulart IM
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):457-67. PubMed ID: 15755200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on the two articles entitled "Cutaneous Responses to Antigens and Irritants in Patients of Leprosy" and "Assessment of Diluted Dharmendra Lepromin".
    Sengupta U; Ramu G; Desikan KV
    Lepr India; 1981 Apr; 53(2):328-32. PubMed ID: 7253583
    [No Abstract]   [Full Text] [Related]  

  • 11. Lepromatous leprosy: a review and case report.
    Chimenos Küstner E; Pascual Cruz M; Pinol Dansis C; Vinals Iglesias H; Rodríguez de Rivera Campillo ME; López López J
    Med Oral Patol Oral Cir Bucal; 2006 Nov; 11(6):E474-9. PubMed ID: 17072249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of the lepromin reaction and immunity to leprosy, 1933-1953].
    ROTBERG A
    Rev Bras Leprol; 1955; 23(1-4):1-22. PubMed ID: 13389914
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy.
    Goulart LR; Ferreira FR; Goulart IM
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):91-8. PubMed ID: 16965356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lepromin hypersensitivity induced by integral lepromin in persons presumably free from leprosy.
    OLMOS CASTRO N; ARCURI PB
    Int J Lepr; 1957; 25(4, Part 1):375-9. PubMed ID: 13562945
    [No Abstract]   [Full Text] [Related]  

  • 15. [Positivization in lepromin reaction in cases of leprosy: a) in active causes; b) in negative or arrested cases].
    SCHUJMAN S
    Sem Med; 1955 Apr; 106(14):401-8. PubMed ID: 14385964
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lepromin reaction and electrophoretic changes in patients of non-leprous systemic diseases].
    FIORILLO AM; BECHELLI LM
    Rev Bras Leprol; 1956; 24(4):189-96. PubMed ID: 13420749
    [No Abstract]   [Full Text] [Related]  

  • 17. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
    Mohanty KK; Joshi B; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescrutinizing of lepromin reaction, in particular, of Mitsuda's reaction.
    SATO S; FUKUDA M; KAMIKAWA Y; MAJIMA S; ABE H; TAKEDA M
    Sci Rep Res Inst Tohoku Univ Med; 1957 Jul; 7(4):335-49. PubMed ID: 13495508
    [No Abstract]   [Full Text] [Related]  

  • 19. PCR-restriction fragment length polymorphism analysis as a tool for Mycobacterium species identification in lepromas for lepromin production.
    Alban SM; Sella SR; Miranda RN; Mira MT; Soccol VT
    Lepr Rev; 2009 Jun; 80(2):129-42. PubMed ID: 19743617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Verification of the effect of BCG in leprosy patients during therapy; histopathological confirmation of lepromin reactions].
    RABELO NETO AV; AZULAY RD; OLIVEIRA SILVA EC; ANDRADE LM
    Rev Bras Leprol; 1956; 24(1-2):48-55. PubMed ID: 13420742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.